Park Ha Biological Technology Co., Ltd. (BYAH)
NASDAQ: BYAH · Real-Time Price · USD
0.2185
-0.0289 (-11.68%)
At close: Dec 5, 2025, 4:00 PM EST
0.2194
+0.0009 (0.41%)
After-hours: Dec 5, 2025, 7:25 PM EST
BYAH Revenue
Park Ha Biological Technology had revenue of $1.24M in the half year ending April 30, 2025, a decrease of -9.65%. This brings the company's revenue in the last twelve months to $2.77M, up 42.65% year-over-year. In the fiscal year ending October 31, 2024, Park Ha Biological Technology had annual revenue of $2.38M, down -3.14%.
Revenue (ttm)
$2.77M
Revenue Growth
+42.65%
P/S Ratio
2.05
Revenue / Employee
$162,831
Employees
17
Market Cap
7.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 2.38M | -77.25K | -3.14% |
| Oct 31, 2023 | 2.46M | 539.71K | 28.12% |
| Oct 31, 2022 | 1.92M | 988.35K | 106.16% |
| Oct 31, 2021 | 931.04K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBYAH News
- 6 weeks ago - Park Ha Biological Technology Co., Ltd. Announces Nasdaq Ticker Symbol Change to BYAH - GlobeNewsWire
- 1 year ago - Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering - GlobeNewsWire
- 1 year ago - Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering - GlobeNewsWire
- 1 year ago - Park Ha Biological Aims For U.S. IPO At Sky-High Valuation - Seeking Alpha
- 1 year ago - U.S. IPO Weekly Recap: Small Issuers Close Out August IPO Market - Seeking Alpha